Last 1.57 INR
Change Today 0.00 / 0.00%
Volume 0.0
RLPH On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:40 AM 04/4/14 All times are local (Market data is delayed by at least 15 minutes).

relish pharmaceuticals ltd (RLPH) Snapshot

Open
--
Previous Close
1.57
Day High
--
Day Low
--
52 Week High
02/18/14 - 68.80
52 Week Low
03/10/14 - 1.57
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
295.9K
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for RELISH PHARMACEUTICALS LTD (RLPH)

Related News

No related news articles were found.

relish pharmaceuticals ltd (RLPH) Related Businessweek News

No Related Businessweek News Found

relish pharmaceuticals ltd (RLPH) Details

Relish Pharmaceuticals Limited manufactures, exports, and markets various drugs and dosage forms in India and internationally. The company’s product portfolio includes antibiotics, macrolides, quinolones, anti bacterial, anti fungal, anti malarial, anti viral, anti protozoal, anti anthelmintic, sedative and tranquilliser, anti depressant, anti manic, anti emetic, anti ulcer, beta blockers, diuretics, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic, and other products. Relish Pharmaceuticals Limited was incorporated in 1993 and is based in Ahmedabad, India.

Founded in 1993

relish pharmaceuticals ltd (RLPH) Top Compensated Officers

Executive Director
Total Annual Compensation: --
Executive Director
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

relish pharmaceuticals ltd (RLPH) Key Developments

Relish Pharmaceuticals Limited Reports Unaudited Standalone Earnings Results for Second Quarter and Six Months Ended September 30, 2014

Relish Pharmaceuticals Limited reported unaudited standalone earnings results for second quarter and six months ended September 30, 2014. For the quarter, the company’s net sales/income from operations (net of excise duty) was INR 10.940 million compared to INR 9.375 million a year ago. Profit from operations before other income, finance cost and exceptional items were INR 0.490 million compared to loss of INR 5.077 million a year ago. Profit from ordinary activities before tax was INR 0.490 million compared to loss of INR 3.418 million a year ago. Net profit was INR 0.490 million or INR 0.03 per basic and diluted share before and after extraordinary items compared to loss of INR 3.418 million or INR 0.03 per basic and diluted share before and after extraordinary items for the same period a year ago. For the six months, the company’s net sales/income from operations (net of excise duty) was INR 18.489 million compared to INR 16.921 million a year ago. Profit from operations before other income, finance cost and exceptional items were INR 0.903 million compared to loss of INR 8.502 million a year ago. Profit from ordinary activities before tax was INR 0.903 million compared to loss of INR 8.502 million a year ago. Net profit was INR 0.903 million or INR 0.06 per basic and diluted share before and after extraordinary items compared to net loss of INR 8.502 million or INR 0.08 per basic and diluted share before and after extraordinary items for the same period a year ago.

Relish Pharmaceuticals Limited, Board Meeting, Nov 13, 2014

Relish Pharmaceuticals Limited, Board Meeting, Nov 13, 2014. Agenda: To consider unaudited standalone earnings results for second quarter and six months ended September 30, 2014.

Relish Pharmaceuticals Limited Approves the Appointment of B. J. Trivedi & Associates as Auditor

Relish Pharmaceuticals Limited at annual general meeting held on September 30, 2014, approved the appointment of B. J. Trivedi & Associates as auditor of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RLPH:IN 1.57 INR 0.00

RLPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RLPH.
View Industry Companies
 

Industry Analysis

RLPH

Industry Average

Valuation RLPH Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 9.4x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RELISH PHARMACEUTICALS LTD, please visit www.relishpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.